You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

IFCT

Showing 1 - 25 of 61
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non Small Cell Lung Cancer, EGFR Activating Mutation, EGFR DEL19 Trial in France (Plasma ctDNA, FFPE blocks)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • +3 more
  • Plasma ctDNA
  • FFPE blocks
  • Angers, France
  • +35 more
Sep 19, 2023

NSCLC Metastatic Trial in France (AZD2014, AZD4547, AZD5363)

Active, not recruiting
  • Non-small Cell Lung Cancer Metastatic
  • Avignon, France
  • +36 more
Jul 29, 2022

French Biological Observatory on Lung Cancer in Never Smokers

Completed
  • Lung Cancer
    • Aix-en-Provence, France
    • +81 more
    Jun 29, 2022

    Non-Small-Cell Lung Carcinoma Trial in France (Radiological Arm, Scannographic arm)

    Completed
    • Non-Small-Cell Lung Carcinoma
    • Radiological Arm
    • Scannographic arm
    • Belfort, France
    • +6 more
    Aug 9, 2022

    Small Cell Lung Cancer Extensive Stage Trial in France, Luxembourg (Carboplatin + Paclitaxel + Durvalumab)

    Not yet recruiting
    • Small Cell Lung Cancer Extensive Stage
    • Carboplatin + Paclitaxel + Durvalumab
    • Abbeville, France
    • +27 more
    May 4, 2023

    Non Small Cell Lung Cancer Metastatic Trial in France (Lorlatinib)

    Recruiting
    • Non Small Cell Lung Cancer Metastatic
    • Aix-en-Provence, France
    • +38 more
    Aug 9, 2022

    Non Small Cell Lung Cancer Metastatic, Leptomeningeal Metastasis, Brain Metastases Trial in France (Osimertinib)

    Recruiting
    • Non Small Cell Lung Cancer Metastatic
    • +3 more
    • Aix-en-Provence, France
    • +36 more
    Jun 28, 2022

    Metastatic NSCLC Trial in France (Pembrolizumab before randomization, Chemotherapy, Pemetrexed)

    Recruiting
    • Metastatic NSCLC
    • Pembrolizumab before randomization
    • +3 more
    • Aix-en-Provence, France
    • +37 more
    Jul 26, 2022

    Neuroendocrine Carcinoma Trial in France (Nivolumab, Ipilimumab)

    Active, not recruiting
    • Neuroendocrine Carcinoma
    • Aix-en-Provence, France
    • +6 more
    Mar 9, 2022

    RW Efficacy of Sotorasib in KRAS G12C-mutated Metastatic NSCLC

    Recruiting
    • Nsclc
    • KRAS P.G12C
      • Paris, France
      • +2 more
      Aug 9, 2022

      Non Small Cell Lung Cancer Metastatic Trial in France (Lorlatinib)

      Recruiting
      • Non Small Cell Lung Cancer Metastatic
      • Angers, France
      • +31 more
      Apr 12, 2022

      Non Small Cell Lung Cancer Trial in France (Paclitaxel, Bevacizumab, Atezolizumab)

      Not yet recruiting
      • Non Small Cell Lung Cancer
      • Amiens, France
      • +42 more
      Mar 10, 2023

      RW Effectiveness of Lurbinectedin in Extensive Stage SCLC

      Completed
      • Small-cell Lung Cancer
      • Paris, France
      • +1 more
      Jan 5, 2023

      NSCLC Stage IV Trial in France (Durvalumab)

      Recruiting
      • Non-small Cell Lung Cancer Stage IV
      • Besançon, France
      • +19 more
      Mar 9, 2022

      Non Small Cell Lung Cancer Trial in France (Afatinib, Cetuximab)

      Completed
      • Non Small Cell Lung Cancer
      • Aix-en-Provence, France
      • +32 more
      Aug 9, 2022

      Atezolizumab Combined With Chemotherapy in Extensive Stage SCLC

      Completed
      • Small Cell Lung Cancer
      • atezolizumab
      • Chalon-sur-Saône, France
      • +1 more
      Jan 5, 2023

      Non Small Cell Lung Cancer, ALK Gene Mutation Trial in France (Brigatinib 180 MG, Carboplatin, Pemetrexed)

      Recruiting
      • Non Small Cell Lung Cancer
      • ALK Gene Mutation
      • Brigatinib 180 MG
      • +2 more
      • Angers, France
      • +31 more
      Aug 9, 2022

      Linac MRI-guided Adaptive Radiotherapy for Locally Advanced

      Recruiting
      • Locally Advanced Cancer
      • MRI Linac
      • Pierre-Benite, France
        Centre Hospitalier Lyon-Sud - Radiotherapie/Oncologie
      Jul 12, 2023

      French National Observatory of Non-small Cell Lung and Molecular

      Completed
      • Carcinoma, Non-Small-Cell Lung
      • +3 more
        • Agen, France
        • +132 more
        Jun 29, 2022

        Non Small Cell Lung Cancer Metastatic, Non Small Cell Lung Cancer Stage III, HER2 Gene Mutation Trial in France (pertuzumab +

        Active, not recruiting
        • Non Small Cell Lung Cancer Metastatic
        • +2 more
        • pertuzumab + trastuzumab + docetaxel
        • Besançon, France
        • +17 more
        Mar 9, 2022

        Stage IV NSCLC Trial in Lyon (observation, gemcitabine, erlotinib)

        Completed
        • Stage IV Non-small Cell Lung Cancer
        • Lyon, France
          Maurice PEROL
        May 23, 2019

        BRAF V600-mutated Lung Carcinoma Treated With Combination of

        Completed
        • Non Small Cell Lung Cancer
        • BRAF V600 Mutation
          • Créteil, France
          • +1 more
          Jun 29, 2022

          NSCLC Metastatic Trial in France (Ipilimumab, Nivolumab)

          Active, not recruiting
          • Non-Small Cell Lung Cancer Metastatic
          • Amiens, France
          • +46 more
          Mar 9, 2022

          Patients With NSCLC Treated With Nivolumab Under the ATU Program

          Completed
          • Non-small Cell Lung Cancer
          • +2 more
            • Aix-En-Provence, France
            • +71 more
            Jun 29, 2022

            NSCLC Trial in France, Germany, United States (Adjuvant Chemotherapy, Radiographic surveillance, 14-Gene Prognostic Assay)

            Recruiting
            • Non-Small Cell Lung Cancer
            • Adjuvant Chemotherapy
            • +2 more
            • Springdale, Arkansas
            • +50 more
            Jan 31, 2023